Artiva Biotherapeutics, Inc. ARTV Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s accumulated depreciation?
- Artiva Biotherapeutics, Inc. (ARTV) reported accumulated depreciation of $9.11M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s accumulated depreciation changed year-over-year?
- Artiva Biotherapeutics, Inc.'s accumulated depreciation increased by 39.4% year-over-year, from $6.53M to $9.11M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s accumulated depreciation?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s accumulated depreciation has grown at a 54.7% compound annual growth rate (CAGR), from $3.53M to $8.46M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.